Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients (MRAHF)

M

Metanoic Health

Status

Completed

Conditions

Mitral Regurgitation
Acute Heart Failure

Treatments

Procedure: Transthoracic Echocardiogram (TTE) Assesment

Study type

Interventional

Funder types

Industry

Identifiers

NCT02728739
MHL-2016-001

Details and patient eligibility

About

The purpose of this study is to determine the prevalence of moderate-to-severe Mitral Regurgitation (MR) in acute Heart Failure (HF) patients requiring hospital admission.

Full description

All patients admitted with symptoms of HF- (shortness of breath (SOB), peripheral oedema, palpitations and irregular heart beats) will be assessed by the Research Team. The level of BNP will be checked using a small device (i-STAT BNP) at the bedside. If results of the test suggest HF they will undergo special procedure called transthoracic echocardiography (TTE). TTE is an ultrasound scan of the heart which will enable the investigators' to grade severity of Mitral Regurgitation (MR) as well as strength of the heart muscle. The investigators will use bi-plane Simpton's method to calculate left ventricular (LV) ejection fraction (EF). Colour Doppler and PISA method will be used to quantify severity of MR or valve leak. Simultaneously there will be recording of heart sounds to find out if auscultation is reliable in identifying leaky valves.

Enrollment

500 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute Heart Failure patients admitted to the Hospital
  • Elevated BNP level (>30pg/ml)

Exclusion criteria

  • Patients with BNP level (< 30pg/ml)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 1 patient group

Acute Heart Failure Patients
Experimental group
Description:
Acute Heart Failure patients with elevated levels of BNP ( >30pg/ml) will undergo Transthoracic Echocardiogram (TTE) for grading of MR severity within 7 days.
Treatment:
Procedure: Transthoracic Echocardiogram (TTE) Assesment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems